CHRONIC BACK PAINS: PROBLEMS AND TREATMENT


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Much importance is attached to the inadequacy of inhibitory cortico-limbic and limbico-reticular influences and to total gamma aminobutyric acid (GABA) deficiency in the development of muscular tonic syndrome in acute and chronic pains. Baclosan (baclofen) is a GABA receptor agonist used as a central myorelaxant. Its clinical application is to treat pain and abnormalities associated with increased muscle tone and spasticity.

全文:

受限制的访问

作者简介

M. Koreshkina

Pain Management Center, Scandinavia Clinic

Email: Koreshkina-MI@avaclinic.ru
Saint Petersburg

参考

  1. Armstrong N., Leadley R., Lee Y.-C. et al. Reflection process on chronic diseases in the EU - the role of chronic pain. - York: Kleijnen Systematic Reviews Ltd., 2011.
  2. Langley P. The prevalence, correlates and treatment of pain in the European Union // Curr. Med. Res. Opin. - 2011; 27 (2): 463-80.
  3. Jakobsson U. The epidemiology of chronic pain in general population: results of a survey in southern Sweden // Scаnd. J. Rheumatol. - 2010; 39 (5): 421-9.
  4. Langley P. The prevalence, correlates and treatment of pain in the European Union // Curr. Med. Res. Opin. - 2011; 27 (2): 463-80.
  5. Hensler S., Heinemann D., Becker M. Pain in German general practice // Pain Med. - 2009; 10 (8): 1408-15.
  6. Raftrry M., Sarma K., Murphu A. et al. Chronica pain in republic of Ireland -community prevalence, psychosocial profile and predictors of pain-related disability: resulta from Prevalence, Impact and Cost Chronic Pain (PRIME) study, part 1 // Pain. - 2011; 152 (5): 1096-103.
  7. Fernandez-de-la-Penas C., Hernandes-Barrera V., Alonso-Blanco C. et al. Prevalence of neck and low back pain in community-dwelling adults in Spain: a population-based national study // Spine. - 2011; 36 (3): 13-9.
  8. Gerde B., Bjork J., Coster L. A Prevalence of widespread pain and association with work status: a population study. BMC // Muscoskelet. Disord. - 2008; 9: 102-7.
  9. Magdi H. Pain in Europe: a public health priority // J. Pain Palliat. Care Pharm. - 2012; 26 (2): 182-4.
  10. Becker A., Held H., Redaelli M. et al. Low back pain in primary care: cost of care and prediction of future health care utilization // Spine. - 2010; 35 (18): 1714-20.
  11. Wieser S., Horisberger B., Schmidhauser S. et al. Cost of low back pain in Switzerland in 2005 // Eur. J. Health. Econ. - 2011; 12 (5): 455-67.
  12. Depont F., Hunsche E., Abouelfath A. et al. medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France // Fundam. Clin. Pharmacol. - 2010; 24 (1): 101-8.
  13. Баринов А. Формирование мышечного спазма, спастичности и хронизации боли // Врач. - 2012; 5: 17-23.
  14. Корешкина М.И. Баклосан (баклофен) в лечении болей в спине: результаты многоцентрового исследования BRAVO // Журн. неврол. и психиат. им. С.С. Корсакова. - 2009; 8; 68-9.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2013